<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00221923</url>
  </required_header>
  <id_info>
    <org_study_id>NEI U10 EY 14267</org_study_id>
    <nct_id>NCT00221923</nct_id>
  </id_info>
  <brief_title>African Descent and Glaucoma Evaluation Study</brief_title>
  <acronym>ADAGES</acronym>
  <official_title>African Descent and Glaucoma Evaluation Study (Formerly African Americans With Glaucoma Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to the National Eye Institute, Glaucoma affects about three million Americans.
      Among Blacks in the United States, open- angle glaucoma is the leading cause of irreversible
      visual loss. Glaucoma is four times more likely to develop in Blacks than in Whites.

      This is a prospective longitudinal, multi- site observational cohort study designed to obtain
      visual function and optic nerve structure data on eyes of Black and White Americans. The
      investigators will evaluate the relationship between changes in the structure of the eye and
      the vision loss caused by glaucoma.This is the first study where both populations are matched
      for quality of care and equal access to care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is:

        1. To further determine the nature of vision loss and optic nerve structural change
           associated with glaucoma. Using recently developed measures of visual function and
           techniques for imaging the eye, we will use a multivariate approach for analysis of the
           functional and structural changes associated with glaucoma to delineate further the
           relationship of these changes to the underlying physiological mechanisms..

        2. To evaluate and improve new diagnostic and monitoring techniques encompassing measures
           of visual function and optic nerve and retina nerve fiber layer structure and to compare
           the rate and patterns of progression of glaucomatous damage in Black and White eyes.

        3. To improve techniques for evaluation of current management and new therapies for
           glaucoma as they become available. We will expand our analysis using multivariate
           techniques incorporating visual function, optic nerve structure, and various risk
           factors to improve detection of true change. We will determine whether the benefits
           found in Whites using visual function specific perimetry and optic disc imaging for
           earlier detection and for monitoring progression are also found for Blacks.

        4. To determine the quantitative temporal relationships between recognizable optic nerve
           damage and measurable visual field loss and how these relationships differ among Black
           and White patients. Using new techniques with improved sensitivity, the detection and
           monitoring of early optic disc defects may provide profiles of people at risk for
           developing glaucomatous visual function loss thus better defining target populations for
           treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2002</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1540</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Healthy individuals</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Persons at risk for or with primary open angle glaucoma</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults of African or European descent based on self-report.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Open angles

          -  Best-corrected acuity of 20/40 or better

          -  Spherical refraction within + 5.0 D, and cylinder within + 3.0 D with plus OR minus
             cylinders

          -  ≥ 18 years old

          -  A family history of glaucoma is allowed

          -  Ability to obtain adequate or better quality stereophotographs

          -  Ability to do reliable standard Humphrey 30-2 or 24-2 visual fields

          -  Participants with glaucoma or at risk for glaucoma or healthy controls

        Exclusion Criteria:

          -  History of intraocular surgery (except uncomplicated cataract or glaucoma surgery)

          -  Problems other than Glaucoma affecting color vision

          -  Non glaucomatous secondary causes of elevated IOP ( e.g. iridocyclitis, trauma)

          -  Other intraocular eye disease

          -  Other diseases affecting visual field (e:g pituitary lesions, demyelinating diseases,
             HIV+ or AIDS, or diabetic retinopathy) with medications known to affect visual field
             sensitivity

          -  Problems other than Glaucoma affecting color vision
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda M Zangwill, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Medeiros, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama-Callahan Eye Foundation, Prof. Bldg.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSD Hamilton Glaucoma Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093-0946</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Eye &amp; Ear Infirmary</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1783-90.</citation>
    <PMID>10845599</PMID>
  </reference>
  <reference>
    <citation>Racette L, Boden C, Kleinhandler SL, Girkin CA, Liebmann JM, Zangwill LM, Medeiros FA, Bowd C, Weinreb RN, Wilson MR, Sample PA. Differences in visual function and optic nerve structure between healthy eyes of blacks and whites. Arch Ophthalmol. 2005 Nov;123(11):1547-53.</citation>
    <PMID>16286617</PMID>
  </reference>
  <reference>
    <citation>Bathija R, Zangwill L, Berry CC, Sample PA, Weinreb RN. Detection of early glaucomatous structural damage with confocal scanning laser tomography. J Glaucoma. 1998 Apr;7(2):121-7.</citation>
    <PMID>9559499</PMID>
  </reference>
  <reference>
    <citation>Zangwill L, Knauer S, Williams JM, Weinreb RN, Retinal fiber layer assessment by scanning laser polarimetery, optical coherence tomography and retinal nerve fiber layer photography. In: Lemij HG, Schuman JS, eds. The Shape of Glaucoma, Quantitative Neural Imaging Techniques. The Hague Kugler Publications, 2000:239-252</citation>
  </reference>
  <reference>
    <citation>Wilson MR. Glaucoma in blacks: where do we go from here? JAMA. 1989 Jan 13;261(2):281-2.</citation>
    <PMID>2909027</PMID>
  </reference>
  <reference>
    <citation>Muñoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB, Bandeen-Roche K. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000 Jun;118(6):819-25.</citation>
    <PMID>10865321</PMID>
  </reference>
  <reference>
    <citation>Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991 Jul 17;266(3):369-74.</citation>
    <PMID>2056646</PMID>
  </reference>
  <reference>
    <citation>Javitt JC, McBean AM, Nicholson GA, Babish JD, Warren JL, Krakauer H. Undertreatment of glaucoma among black Americans. N Engl J Med. 1991 Nov 14;325(20):1418-22.</citation>
    <PMID>1922253</PMID>
  </reference>
  <reference>
    <citation>Sample PA, Weinreb RN, Boynton RM. Acquired dyschromatopsia in glaucoma. Surv Ophthalmol. 1986 Jul-Aug;31(1):54-64. Review.</citation>
    <PMID>3529468</PMID>
  </reference>
  <reference>
    <citation>Sample PA, Weinreb RN. Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1869-75.</citation>
    <PMID>2211033</PMID>
  </reference>
  <reference>
    <citation>Sample PA, Madrid ME, Weinreb RN. Evidence for a variety of functional defects in glaucoma-suspect eyes. J Glaucoma. 1994 Summer;3 Suppl 1:S5-18.</citation>
    <PMID>19920588</PMID>
  </reference>
  <reference>
    <citation>Sample PA, Johnson CA, Haegerstrom-Portnoy G, Adams AJ. Optimum parameters for short-wavelength automated perimetry. J Glaucoma. 1996 Dec;5(6):375-83.</citation>
    <PMID>8946293</PMID>
  </reference>
  <reference>
    <citation>Yamagishi N, Anton A, Sample PA, Zangwill L, Lopez A, Weinreb RN. Mapping structural damage of the optic disk to visual field defect in glaucoma. Am J Ophthalmol. 1997 May;123(5):667-76.</citation>
    <PMID>9152072</PMID>
  </reference>
  <reference>
    <citation>Anton A, Yamagishi N, Zangwill L, Sample PA, Weinreb RN. Mapping structural to functional damage in glaucoma with standard automated perimetry and confocal scanning laser ophthalmoscopy. Am J Ophthalmol. 1998 Apr;125(4):436-46.</citation>
    <PMID>9559728</PMID>
  </reference>
  <reference>
    <citation>Girkin CA, Emdadi A, Sample PA, Blumenthal EZ, Lee AC, Zangwill LM, Weinreb RN. Short-wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping. Arch Ophthalmol. 2000 Sep;118(9):1231-6.</citation>
    <PMID>10980768</PMID>
  </reference>
  <reference>
    <citation>Sample PA. What does functional testing tell us about optic nerve damage? Surv Ophthalmol. 2001 May;45 Suppl 3:S319-24; discussion S332-4. Review.</citation>
    <PMID>11377456</PMID>
  </reference>
  <reference>
    <citation>Bowd C, Zangwill LM, Berry CC, Blumenthal EZ, Vasile C, Sanchez-Galeana C, Bosworth CF, Sample PA, Weinreb RN. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1993-2003.</citation>
    <PMID>11481263</PMID>
  </reference>
  <reference>
    <citation>Goldbaum MH, Sample PA, Chan K, Williams J, Lee TW, Blumenthal E, Girkin CA, Zangwill LM, Bowd C, Sejnowski T, Weinreb RN. Comparing machine learning classifiers for diagnosing glaucoma from standard automated perimetry. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):162-9.</citation>
    <PMID>11773027</PMID>
  </reference>
  <reference>
    <citation>Johnson CA, Sample PA, Cioffi GA, Liebmann JR, Weinreb RN. Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am J Ophthalmol. 2002 Aug;134(2):177-85.</citation>
    <PMID>12140023</PMID>
  </reference>
  <reference>
    <citation>Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and visual function abnormalities in ocular hypertensive patients. Am J Ophthalmol. 2003 Feb;135(2):131-7.</citation>
    <PMID>12566014</PMID>
  </reference>
  <reference>
    <citation>Racette L, Wilson MR, Zangwill LM, Weinreb RN, Sample PA. Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003 May-Jun;48(3):295-313. Review.</citation>
    <PMID>12745004</PMID>
  </reference>
  <reference>
    <citation>Schiefer U, Flad M, Stumpp F, Malsam A, Paetzold J, Vonthein R, Denk PO, Sample PA. Increased detection rate of glaucomatous visual field damage with locally condensed grids: a comparison between fundus-oriented perimetry and conventional visual field examination. Arch Ophthalmol. 2003 Apr;121(4):458-65.</citation>
    <PMID>12695242</PMID>
  </reference>
  <reference>
    <citation>Medeiros FA, Sample PA, Weinreb RN. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol. 2004 May;137(5):863-71.</citation>
    <PMID>15126151</PMID>
  </reference>
  <reference>
    <citation>Sánchez-Galeana CA, Bowd C, Zangwill LM, Sample PA, Weinreb RN. Short-wavelength automated perimetry results are correlated with optical coherence tomography retinal nerve fiber layer thickness measurements in glaucomatous eyes. Ophthalmology. 2004 Oct;111(10):1866-72.</citation>
    <PMID>15465548</PMID>
  </reference>
  <reference>
    <citation>Sample PA, Chan K, Boden C, Lee TW, Blumenthal EZ, Weinreb RN, Bernd A, Pascual J, Hao J, Sejnowski T, Goldbaum MH. Using unsupervised learning with variational bayesian mixture of factor analysis to identify patterns of glaucomatous visual field defects. Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2596-605.</citation>
    <PMID>15277482</PMID>
  </reference>
  <reference>
    <citation>Boden C, Blumenthal EZ, Pascual J, McEwan G, Weinreb RN, Medeiros F, Sample PA. Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol. 2004 Dec;138(6):1029-36.</citation>
    <PMID>15629296</PMID>
  </reference>
  <reference>
    <citation>Stamper R. L., Sample P. A. and Girkin C. A. (Eds.). (2003). Assessing Visual Function in Clinical Practice. Ophthalmology Clinics of North America, Vol.16, Number . In Anderson D.R.(ed.) Standard Perimetry (pp. 205-212).</citation>
  </reference>
  <reference>
    <citation>Stamper R. L., Sample P. A. and Girkin C. A. (Eds.). (2003). Assessing Visual Function in Clinical Practice. Ophthalmology Clinics of North America, Vol.16, Number . In Anderson J.A and Johnson C.A. (eds.). Frequency-Doubling Technology Perminetry (pp213-226)</citation>
  </reference>
  <reference>
    <citation>Stamper R. L., Sample P. A. and Girkin C. A. (Eds.). (2003). Assessing Visual Function in Clinical Practice. Ophthalmology Clinics of North America, Vol.16, Number 2. In Racette L and Sample P.A. (eds.). Short wave automated perimetry. (pp227 -236).</citation>
  </reference>
  <reference>
    <citation>Weinreb R.N. and Greve E.L. (Eds.). (2004). Glaucoma diagnosis. Structure and function. The Hague, The Netherlands: Kugler Publications.</citation>
  </reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>August 29, 2011</last_update_submitted>
  <last_update_submitted_qc>August 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2011</last_update_posted>
  <responsible_party>
    <name_title>Donald Everett/Program Officer</name_title>
    <organization>National Eye Institute</organization>
  </responsible_party>
  <keyword>Primary open angle glaucoma</keyword>
  <keyword>African American</keyword>
  <keyword>Glaucoma/pathology</keyword>
  <keyword>Glaucoma/ physiopathology</keyword>
  <keyword>Nerve Fibers/pathology</keyword>
  <keyword>Risk factor glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

